Based on these discrepancies, the main aim of the current pilot study was to explore if MMPs/TIMP-4 interactions in platelets or plasma are associated with the response to aspirin in patients with diabetes and stable coronary artery disease and whether chronically elevated blood glucose affects MMP-2/TIMP-4 release from platelets. Here, MMP2 is linked to diabetes mellitus.